NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000018263

Registered date:09/07/2015

Which Japanese patients with type 1 diabetes would benefit from continuous subcutaneous insulin infusion?

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedEndocrinology and Metabolism
Date of first enrollment2005/03/01
Target sample size28
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeHbA1c
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriasevere visual impairment, hearing disturbance, and those who could not perform self-monitoring of blood glucose at least four times per day.

Related Information

Contact

public contact
Name Kentaro Taki
Address 3-25-8,nishishinbashi,minato-ku,tokyo Japan
Telephone 03-3433-1111
E-mail tackey@jikei.ac.jp
Affiliation The Jikei university school of medicine Diabetes,metabolism and endocrinology
scientific contact
Name Kentaro Taki
Address 3-25-8,nishi-shinbashi,minato-ku,Tokyo,japan Japan
Telephone 03-3433-1111
E-mail tackey@jikei.ac.jp
Affiliation The Jikei university school of medicine Diabetes,metabolism and endocrinology